The question no one has ever answered is why Amarin would not file this motion if it had merit.
Amarin looked at EVERYTHING, including the Kurabayashi table and testimony; Amarin chose what they thought where their best arguments for appeal. Not everyone at Amarin wanted to let Kurabayashi and Heinecke’s testimony slide...
I have had several back and forth emails with Amarin regarding Rule 60, IMO Amarin chose their strategy poorly.
There’s a very very good chance Du reads our filing....for me that’s a win. Everyone needs to know you might not get justice in her court if she flat out rejects our motion.
Bouf, you raise a good point as to why AMRN is not pursuing this. However I donated anyway as Marjac has spent so many hours with zero payment. And others have as well.
What if Amarin are against the rule 60 filing because that would mean that they are admitting guilt / incompetence / malfeasance (not addressing this during trial)?
Risk / reward? What’s your risk ? A small amount is at risk by those who contribute ...reward ...if successful - immense - even if unsuccessful shareholders will have had their day in court ... they will have tried to right a grave wrong
-shareholders have rights... they have the right to pursue this action -and those shareholders at Du decision date lost greatly
Patients lost greatly -Gv that is not to standard / no educational expenditure by generics
Amarin ... because they do not pursue Rule 60 - you do not what - Consider such that the application has no merit? You rely on the Amarin board /it’s lawyers and just let this go ... what for 500 bucks ?
If Rule 60 wins -Maybe those that do not share this burden should donate their share gains to the American Heart Association !!